Literature DB >> 21436587

Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow.

Yusuke Shiozawa1, Elisabeth A Pedersen, Aaron M Havens, Younghun Jung, Anjali Mishra, Jeena Joseph, Jin Koo Kim, Lalit R Patel, Chi Ying, Anne M Ziegler, Michael J Pienta, Junhui Song, Jingcheng Wang, Robert D Loberg, Paul H Krebsbach, Kenneth J Pienta, Russell S Taichman.   

Abstract

HSC homing, quiescence, and self-renewal depend on the bone marrow HSC niche. A large proportion of solid tumor metastases are bone metastases, known to usurp HSC homing pathways to establish footholds in the bone marrow. However, it is not clear whether tumors target the HSC niche during metastasis. Here we have shown in a mouse model of metastasis that human prostate cancer (PCa) cells directly compete with HSCs for occupancy of the mouse HSC niche. Importantly, increasing the niche size promoted metastasis, whereas decreasing the niche size compromised dissemination. Furthermore, disseminated PCa cells could be mobilized out of the niche and back into the circulation using HSC mobilization protocols. Finally, once in the niche, tumor cells reduced HSC numbers by driving their terminal differentiation. These data provide what we believe to be the first evidence that the HSC niche serves as a direct target for PCa during dissemination and plays a central role in bone metastases. Our work may lead to better understanding of the molecular events involved in bone metastases and new therapeutic avenues for an incurable disease.

Entities:  

Mesh:

Year:  2011        PMID: 21436587      PMCID: PMC3069764          DOI: 10.1172/JCI43414

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

Review 1.  Bone-marrow haematopoietic-stem-cell niches.

Authors:  Anne Wilson; Andreas Trumpp
Journal:  Nat Rev Immunol       Date:  2006-02       Impact factor: 53.106

Review 2.  Uncertainty in the niches that maintain haematopoietic stem cells.

Authors:  Mark J Kiel; Sean J Morrison
Journal:  Nat Rev Immunol       Date:  2008-03-07       Impact factor: 53.106

3.  Granulocyte colony-stimulating factor enhances bone tumor growth in mice in an osteoclast-dependent manner.

Authors:  Angela C Hirbe; Ozge Uluçkan; Elizabeth A Morgan; Mark C Eagleton; Julie L Prior; David Piwnica-Worms; Kathryn Trinkaus; Anthony Apicelli; Katherine Weilbaecher
Journal:  Blood       Date:  2006-12-27       Impact factor: 22.113

4.  Stem cells and cancer: two faces of eve.

Authors:  Michael F Clarke; Margaret Fuller
Journal:  Cell       Date:  2006-03-24       Impact factor: 41.582

5.  Expression and activation of alpha v beta 3 integrins by SDF-1/CXC12 increases the aggressiveness of prostate cancer cells.

Authors:  Yan-Xi Sun; Ming Fang; Jianhua Wang; Carlton R Cooper; Kenneth J Pienta; Russell S Taichman
Journal:  Prostate       Date:  2007-01-01       Impact factor: 4.104

6.  Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells.

Authors:  Orit Kollet; Ayelet Dar; Shoham Shivtiel; Alexander Kalinkovich; Kfir Lapid; Yejezkel Sztainberg; Melania Tesio; Robert M Samstein; Polina Goichberg; Asaf Spiegel; Ari Elson; Tsvee Lapidot
Journal:  Nat Med       Date:  2006-05-21       Impact factor: 53.440

7.  The evolving biology and treatment of prostate cancer.

Authors:  Russel S Taichman; Robert D Loberg; Rohit Mehra; Kenneth J Pienta
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

8.  Annexin II expressed by osteoblasts and endothelial cells regulates stem cell adhesion, homing, and engraftment following transplantation.

Authors:  Younghun Jung; Jingcheng Wang; Junhui Song; Yusuke Shiozawa; Jianhua Wang; Aaron Havens; Zhuo Wang; Yan-Xi Sun; Stephen G Emerson; Paul H Krebsbach; Russell S Taichman
Journal:  Blood       Date:  2007-03-14       Impact factor: 22.113

9.  An in vivo mouse model for human prostate cancer metastasis.

Authors:  Aaron M Havens; Elisabeth A Pedersen; Yusuke Shiozawa; Chi Ying; Younghun Jung; Yanxi Sun; Chris Neeley; Jincheng Wang; Rohit Mehra; Evan T Keller; Laurie K McCauley; Robert D Loberg; Kenneth J Pienta; Russell S Taichman
Journal:  Neoplasia       Date:  2008-04       Impact factor: 5.715

10.  The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer.

Authors:  Jianhua Wang; Yusuke Shiozawa; Jincheng Wang; Yu Wang; Younghun Jung; Kenneth J Pienta; Rohit Mehra; Robert Loberg; Russell S Taichman
Journal:  J Biol Chem       Date:  2007-12-05       Impact factor: 5.486

View more
  321 in total

Review 1.  The connectivity of lymphogenous and hematogenous tumor cell dissemination: biological insights and clinical implications.

Authors:  Jonathan P Sleeman; Blake Cady; Klaus Pantel
Journal:  Clin Exp Metastasis       Date:  2012-06-06       Impact factor: 5.150

Review 2.  CXCR4-based imaging agents.

Authors:  Lauren E Woodard; Sridhar Nimmagadda
Journal:  J Nucl Med       Date:  2011-11       Impact factor: 10.057

3.  Myeloma as a model for the process of metastasis: implications for therapy.

Authors:  Irene M Ghobrial
Journal:  Blood       Date:  2012-04-24       Impact factor: 22.113

Review 4.  Getting blood from bone: an emerging understanding of the role that osteoblasts play in regulating hematopoietic stem cells within their niche.

Authors:  Yusuke Shiozawa; Russell S Taichman
Journal:  Exp Hematol       Date:  2012-05-26       Impact factor: 3.084

Review 5.  Cancer Stem Cells: The Architects of the Tumor Ecosystem.

Authors:  Briana C Prager; Qi Xie; Shideng Bao; Jeremy N Rich
Journal:  Cell Stem Cell       Date:  2019-01-03       Impact factor: 24.633

Review 6.  Cancer stem cells and their role in metastasis.

Authors:  Yusuke Shiozawa; Biao Nie; Kenneth J Pienta; Todd M Morgan; Russell S Taichman
Journal:  Pharmacol Ther       Date:  2013-02-04       Impact factor: 12.310

Review 7.  Regulation of hematopoietic stem cells by bone marrow stromal cells.

Authors:  Bryan A Anthony; Daniel C Link
Journal:  Trends Immunol       Date:  2013-11-05       Impact factor: 16.687

Review 8.  MicroRNAs in the control of metastatic bone disease.

Authors:  Gillian Browne; Hanna Taipaleenmäki; Gary S Stein; Janet L Stein; Jane B Lian
Journal:  Trends Endocrinol Metab       Date:  2014-05-05       Impact factor: 12.015

9.  Selection and adaptation during metastatic cancer progression.

Authors:  Christoph A Klein
Journal:  Nature       Date:  2013-09-19       Impact factor: 49.962

10.  Tumor-infiltrating mesenchymal stem cells: Drivers of the immunosuppressive tumor microenvironment in prostate cancer?

Authors:  Timothy E Krueger; Daniel L J Thorek; Alan K Meeker; John T Isaacs; W Nathaniel Brennen
Journal:  Prostate       Date:  2018-11-28       Impact factor: 4.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.